FDA-AACR: Liquid Biopsies in Oncology Drug and Device Development Workshop
The workshop is already fully booked but space is still available for the live webcast. For more information and to register for the webcast please click here.
- Session I – Cancer Liquid Biopsies: State of the Science
- Session II – Liquid Biopsies in Lung Cancer Drug Development and Clinical Use
- Session III – Liquid Biopsy Test Development
- Session IV – Accelerating Liquid Biopsy Applications to Improve Patient Care
miRNA Work Package Meeting
Date: May 13, 2016
Place: Hilden (QIAGEN site)
2nd General Assembly Meeting
Date: March 21-22, 2016
2nd Steering Committee Meeting
Date: January 25, 2016
Critical Path Innovation Meeting with FDA representatives
CANCER-ID had the unique chance to have a Critical Path Innovation Meeting (CPIM) with representatives of the FDA in order to discuss regulatory aspects of CTC, ctDNA and miRNA based companion diagnostic development. A lot of partners of the CANCER-ID consortium were interested and joined the meeting in form of a teleconference on October 20 2015.
For more information about CPIM please click here.
1st Steering Committee Meeting
Date: September 21st, 2015
1st DLA Workshop in Düsseldorf
Date: May 19, 2015
Place: University Hospital Düsseldorf
CANCER-ID Kick-Off Meeting in Amsterdam
February 5-6, 2015, The Hampshire Manor Hotel Amsterdam